LUTATHERA® Funded in Quebec
As of September 30, 2020, the Québec Ministry of Health and Social Services has listed Lutathera on the Liste de Médicaments – Établissements. Lutathera will be reimbursed for GEP-NETs patients [...]
LUTATHERA® Funded in Nova Scotia
As of August 1, 2020, patients with midgut, GEP-NETs will now be eligible for treatment with LUTATHERA® [lutetium (177Lu) oxodotreotide]. This listing covers adult patients with somatostatin receptor-positive (SSR+) midgut [...]
#HoofingIt launches at Peggy’s Cove July 1
HOOFING IT - The summer-long fundraiser launched at Peggy's Cove on July 1st. Sharon Needham, lung neuroendocrine cancer survivor and advocate; family, friends, supporters kicked-off HOOFING IT with a [...]
#HoofingIt fundraiser launches at Peggy’s Cove July 1
#HoofingIt across Canada to fight one of the fastest-growing class of cancers Canadian Neuroendocrine Tumour Society (CNETS) launches fundraising challenge at Peggy’s Cove July 1, 2020 HALIFAX [...]
Health Canada Approval of NETSPOT®
Advanced Accelerator Applications Announces Health Canada Approval of NETSPOT® Diagnostic Imaging Agent Kit to Detect Neuroendocrine Tumours NETSPOT® is the first and only kit for the preparation of [...]
New Delivery System for Somatuline® Autogel®
Ipsen Announces the Availability of the Newly Designed Delivery System for Somatuline® Autogel® (lanreotide injection) Ipsen Biopharmaceuticals Canada Inc. today announced the availability of a new delivery system for [...]
President’s Message – Summer NETNEWS
It is my pleasure to once again share a quick note on the work of CNETS Canada over the past several months. As always, we have been incredibly busy [...]
AWARENESS COMMITTEE / COMITÉ SENSIBILISATION
CNETS Canada is looking for volunteers to join our NET Cancer Awareness Committee. Specific knowledge of NETs or charitable experience is not required but will be considered an asset. [...]
68Ga-DOTATATE PET scan in Ontario
68Ga-DOTATATE PET scan in Ontario Cancer Care Ontario has announced that as of April 1st, 2019, Ontario patients with neuroendocrine tumours (NETs) meeting eligibility criteria are able to have [...]
2019 National NET Patient Conference LIVE-STREAM
Join CNETS Canada 2019 National NET Patient Conference's video & audio conference by clicking the following link: https://freeman.meetngreet.ca/join/x1GxoRj3UO 2019 NATIONAL NET PATIENT CONFERENCE LIVE-STREAM Saturday April 6, 2019 from [...]